India's Supreme Court has postponed until Sept. 11 a crucial hearing over whether to grant...

|By:, SA News Editor

India's Supreme Court has postponed until Sept. 11 a crucial hearing over whether to grant patent protection to Novartis' (NVS) leading cancer drug Glivec, which the Indian government declined to provide. The hearing was due to take place today. The decision could affect how Big Pharma operates in India, and curb the country's leading position as a supplier of cut-price generic medicines. (previous)